Table of Contents

1. Introduction: Why AI in Public Health Matters

1.1 The Growing Role of AI in Public Health

AI in Public Health is rapidly transforming how infectious diseases are detected, monitored, and managed worldwide. As healthcare systems face growing challenges from emerging diseases, antimicrobial resistance, climate change, and global travel, artificial intelligence is becoming an increasingly important tool for supporting faster and more informed public health decisions.

According to a recent Lancet Infectious Diseases study by Odone et al. (2026), AI has the potential to revolutionize infectious disease prevention and management by supporting clinical care, public health surveillance, and scientific research. The authors argue that AI in Public Health could become one of the most important technological innovations for improving disease prevention, outbreak response, and healthcare efficiency.

Although AI has recently gained widespread attention through technologies such as ChatGPT and other large language models, its use in healthcare is not new. One of the earliest infectious disease applications was the MYCIN expert system developed in the 1970s to recommend antibiotic treatments. Since then, advances in machine learning, deep learning, natural language processing, and generative AI have significantly expanded the capabilities of AI systems (Odone et al., 2026).

Today, AI can analyze massive amounts of data in real time, helping researchers and public health professionals identify patterns, predict risks, and support evidence-based decision-making.

1.2 AI in Public Health for Infectious Diseases in a Connected World

Modern infectious disease threats are becoming increasingly complex. Globalization, rapid urbanization, environmental change, climate variability, and antimicrobial resistance have created conditions that allow infectious diseases to spread faster and affect larger populations than ever before (Odone et al., 2026).

Traditional surveillance systems often struggle to process the enormous volume of information generated by hospitals, laboratories, public health agencies, environmental monitoring networks, and digital platforms. This is where AI in Public Health offers significant advantages.

The Lancet study highlights how AI systems can integrate information from multiple sources, including clinical records, pathogen genomic data, epidemiological surveillance systems, climate observations, wastewater monitoring, mobility data, and even social media activity (Odone et al., 2026). By combining these diverse datasets, AI can improve disease surveillance, support outbreak detection, and strengthen public health preparedness.

This ability to connect and analyze complex data streams makes AI particularly valuable for addressing emerging infectious disease threats in an increasingly interconnected world.

1.3 Insights from The Lancet Study on AI in Public Health

To better understand the role of AI in infectious disease prevention and management, Odone et al. (2026) proposed a comprehensive conceptual framework that maps how AI can be applied across healthcare, public health, and scientific research.

The framework identifies three major areas where AI in Public Health can contribute:

Clinical care and patient support
Epidemiology, surveillance, and disease forecasting
Research, pathogen characterization, and drug development

According to the authors, AI can improve diagnostic accuracy, support outbreak forecasting, enhance infection prevention strategies, accelerate scientific discovery, and strengthen public health preparedness. At the same time, they emphasize that AI should support—not replace—healthcare professionals and public health experts.

The study also highlights important challenges, including data quality, algorithmic bias, privacy concerns, lack of real-world validation, and unequal access to digital technologies. Addressing these issues will be essential for ensuring that AI in Public Health delivers meaningful benefits while maintaining trust, transparency, and health equity (Odone et al., 2026).

As this article explores, AI in Public Health is no longer a future possibility. It is already influencing how infectious diseases are monitored, predicted, and managed, with the potential to transform public health systems worldwide.

2. What Is AI in Public Health?

Artificial intelligence is rapidly becoming a powerful tool for addressing some of the most pressing public health challenges of the modern era. From disease surveillance and outbreak prediction to clinical decision support and scientific research, AI in Public Health is transforming how health data are collected, analyzed, and applied. According to Odone et al. (2026), AI offers unprecedented opportunities to improve infectious disease prevention and management by converting large and complex datasets into actionable insights.

Unlike traditional analytical approaches, AI systems can continuously learn from data, recognize hidden patterns, and generate predictions that support faster and more informed public health decisions. As a result, AI in Public Health is increasingly being integrated into healthcare systems, research institutions, and disease surveillance networks worldwide.

2.1 Understanding Modern AI Technologies

At its core, artificial intelligence refers to computer systems that can perform tasks that typically require human intelligence. These tasks include learning from data, recognizing patterns, making predictions, understanding language, and supporting decision-making processes (Odone et al., 2026).

The Lancet study describes AI as an umbrella term that encompasses a wide range of computational approaches and technologies. Rather than relying solely on pre-programmed instructions, modern AI systems can analyze large datasets and adapt their behavior based on new information. This ability makes AI in Public Health particularly useful for managing complex infectious disease challenges where data are continuously changing.

In public health settings, AI technologies can process information from multiple sources simultaneously, including electronic health records, laboratory reports, pathogen genomic data, environmental monitoring systems, climate observations, wastewater surveillance programs, mobility datasets, and social media platforms (Odone et al., 2026). By integrating these diverse data streams, AI can help identify emerging threats and support timely interventions.

The growing availability of digital health data is one of the major reasons why AI in Public Health has gained significant attention in recent years.

2.2 Machine Learning, Deep Learning, and Large Language Models

Several branches of AI are contributing to advances in infectious disease prevention and management. Among the most important are machine learning, deep learning, and large language models (LLMs).

Machine Learning (ML) is a subset of AI that enables computers to learn patterns from data without being explicitly programmed for every task. In infectious disease applications, machine learning algorithms can be used to predict disease outbreaks, classify infections, identify risk factors, and improve surveillance systems (Odone et al., 2026).

A more advanced form of machine learning is Deep Learning (DL), which uses artificial neural networks inspired by the structure of the human brain. Deep learning models are particularly effective for analyzing large and complex datasets such as medical images, genomic sequences, and real-time surveillance data. The Lancet study highlights that deep learning has become increasingly important for disease detection and predictive modeling because of its ability to automatically identify complex patterns within data (Odone et al., 2026).

Another rapidly evolving technology is the Large Language Model (LLM). These models are trained on vast amounts of text and can understand, generate, and summarize human language. According to Odone et al. (2026), LLMs have the potential to support healthcare professionals by assisting with information retrieval, clinical documentation, scientific literature analysis, and public health communication.

Together, machine learning, deep learning, and large language models form the technological foundation of many modern AI in Public Health applications.

2.3 How AI Supports Public Health Decisions

One of the most important advantages of AI in Public Health is its ability to support evidence-based decision-making. Public health agencies must often make rapid decisions based on enormous amounts of information collected from multiple sources. Traditional methods can be time-consuming and may struggle to keep pace with rapidly evolving situations such as infectious disease outbreaks.

The Lancet framework explains that AI can assist public health decision-makers by transforming complex datasets into useful knowledge that supports planning, surveillance, prevention, and response activities (Odone et al., 2026). For example, AI models can identify unusual disease patterns, forecast outbreak trajectories, estimate transmission risks, and evaluate the potential impact of interventions.

AI can also help integrate information from pathogen surveillance, environmental monitoring, climate observations, and healthcare systems into a unified analytical framework. This capability enables public health officials to gain a more comprehensive understanding of disease dynamics and respond more effectively to emerging threats.

Importantly, the authors emphasize that AI should be viewed as a decision-support tool rather than a replacement for human expertise. Public health professionals remain responsible for interpreting results, validating evidence, considering ethical implications, and making final decisions. The most effective approach combines advanced AI technologies with human knowledge, experience, and professional judgment (Odone et al., 2026).

As AI technologies continue to evolve, their role in disease surveillance, outbreak forecasting, and infectious disease management is expected to expand significantly. This growing integration highlights why AI in Public Health is becoming a critical component of modern healthcare and public health systems worldwide.

3. AI-Powered Disease Surveillance

Disease surveillance is one of the most important functions of public health systems. Effective surveillance helps health authorities monitor disease patterns, identify emerging threats, and implement timely interventions to prevent outbreaks from spreading. However, traditional surveillance systems often struggle to process the massive volumes of information generated by modern healthcare, laboratory, environmental, and digital monitoring networks.

According to Odone et al. (2026), AI in Public Health is transforming disease surveillance by enabling faster data analysis, real-time monitoring, early outbreak detection, and the integration of diverse information sources. By combining machine learning, advanced analytics, and large-scale data processing, AI-powered surveillance systems can provide valuable insights that improve public health preparedness and response.

As infectious disease threats become increasingly complex and interconnected, AI is emerging as a critical tool for strengthening surveillance capabilities worldwide.

3.1 Real-Time Disease Monitoring

One of the most promising applications of AI in Public Health is real-time disease monitoring. Traditional surveillance systems often rely on manual reporting processes that can introduce delays between disease occurrence and public health response. In contrast, AI systems can continuously analyze incoming data streams and identify important trends as they emerge (Odone et al., 2026).

The Lancet study highlights that AI can process information from multiple sources simultaneously, including electronic health records, laboratory testing results, epidemiological surveillance databases, pathogen genomic data, mobility datasets, and digital health platforms. By integrating these data sources, AI can help public health authorities monitor disease activity more efficiently and identify unusual patterns that may require investigation (Odone et al., 2026).

Machine learning models can also recognize subtle changes in disease incidence that might not be immediately apparent through traditional analytical approaches. This capability allows health agencies to detect shifts in transmission dynamics earlier and respond more quickly to potential threats.

As a result, real-time disease monitoring has become one of the most important areas where AI in Public Health can improve situational awareness and support evidence-based decision-making.

3.2 Early Outbreak Detection

Early detection is essential for controlling infectious disease outbreaks. The sooner an outbreak is identified, the greater the opportunity to implement interventions that reduce transmission and limit public health impacts.

According to Odone et al. (2026), AI-based surveillance systems can significantly enhance outbreak detection by analyzing large and diverse datasets in near real time. These systems can identify abnormal disease patterns, unusual clusters of symptoms, or changes in healthcare utilization that may indicate the emergence of an infectious disease event.

The authors discuss examples such as EPIWATCH, an AI-assisted epidemic intelligence platform that collects and analyzes information from open-source data, including news reports and online information streams. Such systems use artificial intelligence to identify signals that may indicate emerging outbreaks before they are formally recognized through conventional surveillance channels (Odone et al., 2026).

AI can also support genomic surveillance by analyzing pathogen sequencing data to detect new variants and monitor disease evolution. This capability became particularly important during the COVID-19 pandemic, when rapid identification of viral variants helped inform public health responses and risk assessments.

By improving the speed and accuracy of outbreak detection, AI in Public Health has the potential to strengthen epidemic preparedness and reduce the impact of future infectious disease emergencies.

3.3 Wastewater and Environmental Surveillance

The Lancet framework emphasizes that effective infectious disease surveillance extends beyond hospitals and clinical settings. Environmental monitoring is becoming an increasingly important component of modern public health surveillance systems, particularly for detecting disease transmission at the population level (Odone et al., 2026).

One notable example is wastewater surveillance, which gained widespread attention during the COVID-19 pandemic. Wastewater monitoring can provide early indications of disease circulation within communities by detecting pathogen genetic material before large numbers of clinical cases are reported. According to Odone et al. (2026), AI can enhance wastewater surveillance by analyzing complex environmental datasets, identifying trends, and generating early warning signals for public health authorities.

The study also highlights the potential of integrating environmental and climate-related information into disease surveillance systems. AI models can combine epidemiological data with environmental observations, mobility information, and other contextual variables to improve understanding of disease transmission patterns and support more accurate risk assessments (Odone et al., 2026).

This approach is particularly relevant for diseases influenced by environmental conditions, including vector-borne diseases and climate-sensitive infectious diseases. By incorporating environmental intelligence into surveillance systems, AI can help public health agencies anticipate emerging risks and allocate resources more effectively.

Overall, wastewater monitoring and environmental surveillance demonstrate how AI in Public Health is expanding the scope of disease monitoring beyond traditional healthcare settings. These innovative approaches provide additional layers of information that can strengthen early warning systems and improve public health preparedness in an increasingly interconnected world.

The growing use of AI-powered disease surveillance illustrates one of the most practical and impactful applications of artificial intelligence in public health today. By supporting real-time monitoring, early outbreak detection, and environmental surveillance, AI is helping health authorities move from reactive responses toward more proactive and predictive public health strategies (Odone et al., 2026).

4. Disease Forecasting and Pandemic Prediction

One of the most exciting applications of AI in Public Health is its ability to forecast disease outbreaks before they become large-scale public health emergencies. Traditional epidemiological models have long been used to predict disease spread, but they often struggle to process the enormous volumes of data generated by modern surveillance systems. Artificial intelligence offers a new approach by analyzing complex and rapidly changing datasets, identifying hidden patterns, and generating predictive insights in near real time.

According to Odone et al. (2026), AI has the potential to significantly improve disease forecasting, outbreak preparedness, and public health decision-making by integrating information from multiple sources and transforming data into actionable knowledge. As emerging infectious diseases continue to threaten global health, predictive AI systems are becoming increasingly valuable for supporting proactive public health responses.

4.1 AI-Based Epidemic Forecasting

Epidemic forecasting involves predicting how infectious diseases may spread across populations over time. Accurate forecasts can help public health agencies prepare healthcare resources, implement interventions, and reduce the impact of outbreaks.

The Lancet study highlights that AI models can process large volumes of epidemiological data and identify transmission patterns that may be difficult to detect using traditional statistical approaches (Odone et al., 2026). Machine learning algorithms can learn from historical disease records, surveillance data, mobility patterns, and healthcare information to estimate future disease trends and transmission dynamics.

Unlike conventional models that often rely on predefined assumptions, AI systems can continuously update predictions as new data become available. This adaptability makes AI in Public Health particularly useful during rapidly evolving outbreaks where disease patterns can change quickly.

The authors note that AI-powered forecasting systems can support epidemic intelligence by helping public health authorities anticipate future risks and respond more effectively to emerging threats. By improving the accuracy and timeliness of disease forecasts, AI can strengthen preparedness efforts and support evidence-based public health planning (Odone et al., 2026).

4.2 Climate and Disease Prediction

Environmental and climatic conditions play an important role in the transmission of many infectious diseases. Temperature, rainfall, humidity, and other environmental factors can influence pathogen survival, vector populations, and human exposure risks.

According to Odone et al. (2026), one of the strengths of AI in Public Health is its ability to integrate environmental and climate-related datasets with epidemiological information. This capability allows researchers to develop predictive models that consider both biological and environmental drivers of disease transmission.

The study highlights how AI systems can combine climate observations, environmental monitoring data, mobility information, and surveillance records to improve disease forecasting. Such approaches are particularly relevant for vector-borne diseases, where environmental conditions strongly influence the distribution and activity of disease-carrying organisms.

By incorporating climate variables into predictive models, AI can help identify regions that may face increased disease risks in the future. This information can support early warning systems, guide resource allocation, and improve preparedness strategies for climate-sensitive infectious diseases (Odone et al., 2026).

The ability to connect environmental intelligence with disease surveillance represents a major advancement in predictive public health analytics.

4.3 Predicting Emerging Infectious Diseases

The emergence of new infectious diseases remains one of the greatest challenges facing global public health. Recent outbreaks have demonstrated how rapidly novel pathogens can spread across countries and continents, emphasizing the importance of early detection and risk assessment.

Odone et al. (2026) explain that AI can contribute to the prediction of emerging infectious diseases by integrating diverse sources of information, including epidemiological surveillance data, pathogen genomic sequences, environmental observations, mobility datasets, and digital information streams. By analyzing these complex datasets simultaneously, AI systems can identify unusual patterns that may indicate the emergence of a new health threat.

The authors also discuss the growing role of AI in genomic surveillance. Machine learning algorithms can analyze pathogen genomes to monitor evolutionary changes, identify new variants, and support risk assessment efforts. These capabilities became particularly important during the COVID-19 pandemic, when rapid genomic analysis helped researchers and public health agencies track viral evolution and assess emerging variants (Odone et al., 2026).

In addition, AI-assisted epidemic intelligence platforms can continuously monitor global information sources and identify signals associated with unusual disease activity. These systems can provide valuable early warnings that support faster public health responses and improve preparedness for future outbreaks.

While AI cannot predict every emerging infectious disease event, the study suggests that it can significantly enhance the ability of public health systems to detect risks earlier and respond more effectively. As surveillance networks become increasingly data-rich, AI-powered forecasting and prediction tools are expected to play an increasingly important role in global health security.

5. AI in Clinical Infectious Disease Management

Beyond disease surveillance and outbreak forecasting, AI in Public Health is increasingly transforming clinical infectious disease management. Healthcare professionals often face enormous challenges when diagnosing infections, interpreting complex medical data, selecting appropriate treatments, and managing antimicrobial resistance. Artificial intelligence offers new tools that can support these clinical decisions while improving efficiency and patient outcomes.

According to Odone et al. (2026), AI applications in clinical infectious diseases span multiple areas, including diagnosis, medical imaging, treatment selection, infection prevention, and antimicrobial stewardship. By analyzing large amounts of clinical and laboratory data, AI systems can assist healthcare providers in making faster and more informed decisions.

Importantly, the Lancet study emphasizes that AI is designed to support clinical practice rather than replace healthcare professionals. Human expertise remains essential for interpreting results, evaluating clinical context, and making final treatment decisions.

5.1 Faster Diagnosis

Timely diagnosis is one of the most important factors influencing infectious disease outcomes. Delays in diagnosis can increase disease transmission, complicate treatment, and worsen patient prognosis. Traditional diagnostic processes often require multiple tests and expert interpretation, which can be time-consuming, especially during outbreaks or in resource-limited settings.

According to Odone et al. (2026), AI systems can assist clinicians by rapidly analyzing clinical information, laboratory results, and pathogen-related data to support diagnostic decision-making. Machine learning models can identify patterns associated with specific infections and help distinguish between different disease conditions.

The authors highlight that AI can process large datasets more quickly than conventional approaches, potentially reducing diagnostic delays and improving clinical workflows. AI-driven decision-support systems may also help healthcare professionals prioritize cases, identify high-risk patients, and recommend appropriate diagnostic pathways.

As healthcare systems continue to generate increasing volumes of digital health data, AI-assisted diagnosis is becoming an important component of modern infectious disease management.

5.2 Medical Imaging Applications

Medical imaging plays a critical role in diagnosing and monitoring many infectious diseases. Radiological examinations such as chest X-rays, computed tomography (CT) scans, and other imaging modalities often provide essential information for clinical assessment.

The Lancet study identifies medical imaging as one of the most active areas of AI development in healthcare. Deep learning algorithms have demonstrated the ability to analyze medical images and identify patterns associated with infectious diseases, supporting clinicians in image interpretation and diagnostic assessment (Odone et al., 2026).

AI-based image analysis can help detect abnormalities, improve diagnostic consistency, and reduce the workload associated with large imaging datasets. During infectious disease outbreaks, these capabilities may assist healthcare providers in rapidly evaluating patients and prioritizing clinical care.

The authors note that AI-driven imaging tools are particularly valuable because they can analyze complex visual information with high efficiency. However, they also emphasize that imaging results should always be interpreted within the broader clinical context and in conjunction with professional medical judgment (Odone et al., 2026).

As imaging technologies and AI algorithms continue to advance, their integration into infectious disease management is expected to become increasingly common.

5.3 Treatment and Antimicrobial Stewardship

Selecting the right treatment is a critical aspect of infectious disease management. Clinicians must consider pathogen characteristics, patient conditions, treatment effectiveness, and potential resistance patterns when making therapeutic decisions.

One area receiving growing attention is antimicrobial stewardship, which aims to optimize antimicrobial use while reducing the development of antimicrobial resistance. Odone et al. (2026) identify antimicrobial resistance as one of the major global health challenges where AI can provide valuable support.

AI systems can analyze microbiological data, antimicrobial susceptibility information, patient records, and treatment outcomes to support evidence-based prescribing decisions. By identifying patterns associated with treatment success or resistance, AI may help clinicians select more effective therapies and reduce unnecessary antimicrobial use.

The study also highlights the potential of AI to assist with treatment optimization by integrating information from multiple clinical and laboratory sources. Such systems can support healthcare providers in managing complex infections while promoting responsible antimicrobial use (Odone et al., 2026).

In addition to treatment selection, AI may contribute to infection prevention and control efforts within healthcare settings by identifying risk factors, monitoring infection trends, and supporting surveillance activities. These capabilities can help healthcare institutions reduce healthcare-associated infections and improve patient safety.

6. AI and Public Health Preparedness

Public health preparedness is essential for protecting populations from infectious disease outbreaks, epidemics, and future pandemics. The COVID-19 pandemic demonstrated how rapidly health emergencies can overwhelm healthcare systems and disrupt societies worldwide. As a result, governments and public health agencies are increasingly exploring how AI in Public Health can strengthen preparedness, improve situational awareness, and support more effective responses to emerging health threats.

According to Odone et al. (2026), artificial intelligence has the potential to enhance public health preparedness by supporting health systems, monitoring disease risks, and improving communication strategies. By transforming large and complex datasets into actionable insights, AI can help decision-makers respond more quickly and efficiently during public health emergencies.

The Lancet framework identifies preparedness as one of the key areas where AI can contribute across clinical practice, public health, and research, helping societies move from reactive crisis management toward proactive risk prevention.

6.1 Supporting Health Systems

Strong healthcare systems are the foundation of effective public health preparedness. During infectious disease outbreaks, health systems must rapidly manage increased patient loads, allocate resources efficiently, and maintain essential healthcare services.

Odone et al. (2026) explain that AI in Public Health can support health systems by improving data analysis, optimizing workflows, and enhancing decision-making processes. AI tools can process large volumes of healthcare information, helping health authorities identify trends, monitor healthcare demands, and anticipate resource needs.

The study highlights how AI can assist in integrating information from clinical records, laboratory testing, surveillance systems, and other healthcare databases. By providing real-time insights, AI can help healthcare organizations respond more effectively to changing epidemiological situations and improve operational efficiency (Odone et al., 2026).

AI can also support preparedness planning by identifying vulnerable populations, estimating disease burdens, and evaluating potential intervention strategies. These capabilities enable healthcare systems to make more informed decisions before and during public health emergencies.

As infectious disease threats continue to evolve, AI-powered decision-support tools may become increasingly important for strengthening healthcare resilience and preparedness.

6.2 Monitoring Public Health Risks

One of the greatest challenges in public health is identifying risks before they develop into major health emergencies. Effective preparedness depends on the continuous monitoring of disease activity, environmental conditions, and other factors that influence health outcomes.

According to Odone et al. (2026), AI systems can integrate diverse sources of information to support comprehensive risk monitoring. These sources may include epidemiological surveillance data, pathogen genomic information, environmental observations, climate data, wastewater surveillance, mobility patterns, and digital information streams.

The ability to combine and analyze these datasets allows AI in Public Health to identify emerging threats more rapidly than traditional surveillance approaches. AI-powered systems can detect unusual patterns, recognize early warning signals, and generate forecasts that support timely public health interventions.

The Lancet study also emphasizes the role of AI in epidemic intelligence, where automated systems continuously monitor information from multiple sources to identify potential disease outbreaks and assess emerging risks (Odone et al., 2026). Such capabilities are particularly valuable in a world where infectious disease threats can spread rapidly across geographic boundaries.

By improving risk detection and situational awareness, AI can help public health agencies allocate resources more effectively and strengthen preparedness efforts.

6.3 Fighting Health Misinformation

Accurate information is a critical component of public health preparedness. During outbreaks and health emergencies, misinformation can spread rapidly, influencing public behavior, reducing trust in health authorities, and undermining response efforts.

The Lancet framework recognizes that communication challenges have become increasingly important in the digital age. Odone et al. (2026) note that AI technologies can support public health communication by analyzing large volumes of online content, identifying misinformation trends, and assisting with information management.

Large language models and natural language processing systems can help public health organizations monitor public discussions, detect misleading narratives, and better understand information needs within communities. These insights can support the development of more effective communication strategies during health emergencies.

At the same time, the authors emphasize that AI itself can contribute to misinformation risks if not used responsibly. Generative AI systems can produce inaccurate or misleading information, making transparency, oversight, and human verification essential components of AI deployment in public health settings (Odone et al., 2026).

For this reason, effective governance and ethical safeguards are necessary to ensure that AI strengthens rather than weakens public trust in health information.

As public health systems continue to evolve, the integration of AI-powered tools may become an increasingly important component of global health security and pandemic preparedness.

7. AI for Pathogen Discovery and Drug Development

One of the most promising applications of AI in Public Health lies in scientific research, particularly in pathogen discovery, genomic analysis, vaccine development, and drug discovery. Infectious disease research generates enormous amounts of biological and genomic data that can be difficult to analyze using traditional methods alone. Artificial intelligence provides powerful tools for processing these complex datasets and uncovering patterns that may accelerate scientific discovery.

According to Odone et al. (2026), AI is increasingly being used to support pathogen characterization, monitor pathogen evolution, identify therapeutic targets, and improve the efficiency of pharmaceutical research. These applications extend beyond clinical care and public health surveillance, highlighting the growing role of AI across the entire infectious disease ecosystem.

As emerging pathogens continue to pose global health risks, AI-driven research tools may help scientists respond more quickly and effectively to future infectious disease threats.

7.1 Tracking Pathogen Evolution

Pathogens are constantly evolving through genetic mutations and adaptations. Understanding these evolutionary changes is essential for monitoring disease transmission, assessing emerging risks, and developing effective control strategies.

The Lancet study highlights pathogen characterization as one of the key domains where AI in Public Health can make significant contributions (Odone et al., 2026). AI systems can analyze large volumes of genomic sequencing data and identify patterns that may be difficult to detect through conventional analytical approaches.

Machine learning algorithms can help researchers monitor genetic variations, track the emergence of new pathogen strains, and evaluate evolutionary trends over time. These capabilities became particularly important during the COVID-19 pandemic, when genomic surveillance was used to identify and monitor new viral variants.

By processing genomic datasets rapidly and efficiently, AI can support scientists in understanding how pathogens evolve, spread, and adapt to changing environments. Such insights are essential for guiding surveillance programs, informing public health responses, and improving preparedness for future outbreaks (Odone et al., 2026).

The ability to track pathogen evolution in near real time represents one of the most valuable contributions of AI to modern infectious disease research.

7.2 Vaccine Development

Developing vaccines is traditionally a complex, time-consuming, and resource-intensive process. Researchers must identify suitable targets, evaluate immune responses, and conduct extensive testing before vaccines can be deployed safely and effectively.

According to Odone et al. (2026), AI technologies are increasingly being explored as tools to support various stages of vaccine development. By analyzing biological, genomic, and immunological data, AI systems can help researchers identify promising vaccine candidates and better understand pathogen characteristics.

AI can assist scientists in examining large datasets that would be difficult to process manually, enabling faster identification of important biological patterns and relationships. These capabilities may help streamline aspects of vaccine research and improve the efficiency of development processes.

The Lancet framework emphasizes that AI-driven approaches have the potential to accelerate scientific discovery by reducing the time required for data analysis and hypothesis generation. Although human expertise remains essential throughout vaccine development, AI can provide valuable decision-support tools that enhance research productivity (Odone et al., 2026).

As infectious disease threats continue to emerge, faster and more efficient vaccine development strategies may play a crucial role in improving global health preparedness.

7.3 Accelerating Drug Discovery

Drug discovery is another area where AI in Public Health is demonstrating significant potential. Identifying new therapeutic compounds often requires extensive laboratory testing, data analysis, and evaluation of complex biological interactions. These processes can take many years and require substantial financial investment.

Odone et al. (2026) identify drug development as one of the important research domains where AI can contribute to infectious disease management. AI systems can analyze large biological datasets, identify potential therapeutic targets, and support the discovery of candidate compounds for further investigation.

Machine learning algorithms can examine complex relationships among pathogens, host responses, and biological pathways, helping researchers prioritize promising research directions. By automating aspects of data analysis and pattern recognition, AI can reduce the time needed to evaluate large numbers of potential drug candidates.

The authors suggest that AI may also support precision approaches to infectious disease treatment by helping researchers better understand disease mechanisms and identify opportunities for targeted interventions. These capabilities have the potential to improve research efficiency and accelerate the development of new therapies (Odone et al., 2026).

Importantly, AI does not replace laboratory experimentation or clinical testing. Instead, it serves as a powerful research tool that helps scientists navigate increasingly complex biological datasets and make more informed decisions throughout the drug development process.

8. Challenges and Limitations of AI in Public Health

While the potential benefits of AI in Public Health are substantial, the Lancet study emphasizes that artificial intelligence is not a perfect solution to infectious disease challenges. Despite rapid technological advances, several important limitations continue to affect the development, deployment, and effectiveness of AI systems in healthcare and public health settings.

According to Odone et al. (2026), successful implementation of AI requires more than advanced algorithms. Data quality, ethical governance, transparency, regulatory oversight, and real-world validation all play critical roles in determining whether AI systems can deliver meaningful and trustworthy outcomes.

Understanding these challenges is essential for ensuring that AI in Public Health is implemented responsibly and effectively.

8.1 Data Quality and Bias

Artificial intelligence systems are only as reliable as the data used to train and evaluate them. One of the most significant challenges identified by Odone et al. (2026) is the issue of data quality. Incomplete, inaccurate, inconsistent, or poorly representative datasets can reduce model performance and generate misleading results.

In infectious disease applications, data often originate from multiple sources, including hospitals, laboratories, surveillance systems, environmental monitoring networks, and public health agencies. Variations in data collection methods, reporting standards, and data availability can create challenges for AI model development and implementation.

Another important concern is algorithmic bias. AI systems learn patterns from existing data, meaning that biases present in the training data may be reflected in model outputs. If certain populations are underrepresented or if datasets contain systematic inequalities, AI systems may produce less accurate results for specific groups (Odone et al., 2026).

The authors note that such biases could potentially contribute to inequitable healthcare outcomes and reduce trust in AI-assisted decision-making. Addressing these challenges requires careful dataset design, rigorous validation procedures, and ongoing monitoring of model performance.

For AI in Public Health to achieve its full potential, ensuring high-quality and representative data must remain a top priority.

8.2 Ethical and Privacy Concerns

The increasing use of AI in healthcare raises important ethical, legal, and social questions. Public health systems often rely on large volumes of personal and health-related data, making privacy protection a critical concern.

According to Odone et al. (2026), many AI applications require access to sensitive information, including electronic health records, genomic data, surveillance databases, and other forms of personal health information. Ensuring the secure collection, storage, and use of these data is essential for maintaining public trust.

Transparency is another major challenge. Many advanced AI models, particularly deep learning systems, function as “black boxes,” making it difficult to fully understand how specific decisions or predictions are generated. This lack of interpretability can create concerns regarding accountability and trust, especially when AI systems influence clinical or public health decisions.

The authors also highlight broader ethical considerations related to fairness, equity, informed consent, and responsible governance. Without appropriate safeguards, AI systems could unintentionally reinforce existing healthcare disparities or create new forms of inequity (Odone et al., 2026).

As AI in Public Health continues to expand, robust ethical frameworks and regulatory oversight will be necessary to ensure that technological innovation aligns with public health values and societal expectations.

8.3 Lack of Real-World Validation

Although many AI models demonstrate impressive performance in research settings, translating these results into real-world public health practice remains a significant challenge.

Odone et al. (2026) emphasize that many published AI studies focus on model development and technical performance while providing limited evidence regarding practical implementation, long-term effectiveness, and real-world impact. A model that performs well under controlled research conditions may not necessarily achieve similar results when deployed within complex healthcare systems.

Differences in healthcare infrastructure, population characteristics, disease patterns, data availability, and operational workflows can all influence AI performance. As a result, extensive external validation is required before AI tools can be confidently integrated into routine public health practice.

The authors also note that many AI applications remain at relatively early stages of development, with limited evidence regarding scalability, sustainability, and cost-effectiveness. Additional research is needed to determine how AI systems perform across different geographic regions, healthcare settings, and population groups (Odone et al., 2026).

For this reason, experts increasingly emphasize the importance of rigorous evaluation, independent validation, and continuous monitoring after deployment. These measures help ensure that AI tools deliver reliable and equitable benefits while minimizing unintended consequences.

9. The Future of AI in Public Health

Artificial intelligence is still in the early stages of its integration into healthcare and public health systems. While current applications already support disease surveillance, outbreak forecasting, clinical decision-making, and infectious disease research, the Lancet study suggests that the future potential of AI in Public Health is far greater. As data availability, computational power, and AI methodologies continue to advance, AI is expected to become an increasingly important component of global public health infrastructure.

According to Odone et al. (2026), the future of AI in infectious diseases will depend on the ability to integrate diverse data sources, strengthen collaboration between disciplines, and ensure responsible implementation through robust governance frameworks. The authors envision a future where AI not only improves healthcare delivery but also strengthens public health preparedness, scientific discovery, and global health security.

9.1 Towards Smarter Disease Surveillance

Disease surveillance systems are becoming increasingly data-rich, generating information from hospitals, laboratories, genomic sequencing programs, environmental monitoring networks, wastewater surveillance systems, and digital platforms. Managing and interpreting these vast datasets is one of the major challenges facing modern public health agencies.

The Lancet framework highlights the potential for AI in Public Health to support next-generation surveillance systems capable of continuously analyzing multiple data streams in real time (Odone et al., 2026). Rather than relying solely on traditional reporting mechanisms, future surveillance systems may incorporate machine learning algorithms that automatically identify unusual disease patterns, detect emerging threats, and generate early warning signals.

Advances in AI could also improve epidemic intelligence by integrating information from local, national, and global surveillance networks. Such systems may help public health authorities anticipate disease outbreaks earlier and respond more effectively to evolving public health risks.

As surveillance technologies continue to evolve, AI-powered systems may play a central role in shifting public health strategies from reactive outbreak response toward proactive prevention and preparedness.

9.2 One Health and Environmental Monitoring

The future of AI in Public Health is closely linked to the growing importance of the One Health approach, which recognizes the interconnected relationships among human health, animal health, and environmental health.

According to Odone et al. (2026), AI has the unique ability to integrate information from diverse domains, making it particularly well suited for supporting One Health initiatives. Infectious diseases often emerge at the interface between humans, animals, and the environment, requiring surveillance systems that extend beyond traditional healthcare settings.

The authors emphasize that future AI applications may increasingly combine epidemiological data with environmental observations, climate information, pathogen surveillance, wastewater monitoring, and animal health data. By integrating these diverse datasets, AI systems can provide a more comprehensive understanding of disease dynamics and emerging health threats.

Environmental monitoring is expected to become particularly important as climate change, urbanization, biodiversity loss, and ecosystem disruptions influence infectious disease transmission patterns. AI-powered analytical tools may help researchers identify environmental drivers of disease, improve risk assessments, and strengthen early warning systems for climate-sensitive infectious diseases (Odone et al., 2026).

The integration of One Health principles into AI-driven public health systems represents a significant opportunity for improving global disease prevention and preparedness.

9.3 Future Research Directions

Although AI technologies have demonstrated substantial promise, the Lancet study emphasizes that many important research questions remain unanswered. Continued scientific investigation will be essential for translating technological advances into practical public health benefits.

Odone et al. (2026) identify several priorities for future research. One major focus is improving the transparency and interpretability of AI systems. Many advanced algorithms operate as complex “black boxes,” making it difficult to understand how predictions and recommendations are generated. Developing more explainable AI models will be important for increasing trust and supporting adoption in healthcare settings.

Another priority involves strengthening model validation and evaluating AI performance under real-world conditions. Future studies must move beyond technical demonstrations and assess how AI systems perform across diverse populations, healthcare systems, and public health environments.

The authors also highlight the importance of addressing ethical, legal, and governance challenges associated with AI deployment. Research is needed to develop frameworks that ensure fairness, privacy protection, accountability, and equitable access to AI technologies.

In addition, interdisciplinary collaboration will play a critical role in advancing AI in infectious diseases. Successful implementation requires cooperation among public health professionals, clinicians, epidemiologists, computer scientists, policymakers, and ethicists (Odone et al., 2026).

Ultimately, the future of AI in Public Health will depend not only on technological innovation but also on responsible implementation, scientific rigor, and effective governance. If these challenges can be addressed, AI has the potential to become one of the most transformative tools for improving infectious disease prevention, public health preparedness, and global health security in the decades ahead.

The vision presented by Odone et al. (2026) is clear: AI should be viewed not as a replacement for human expertise, but as a powerful partner that enhances the ability of healthcare professionals, researchers, and public health agencies to protect population health in an increasingly complex world.

10. Conclusion: Can AI Transform Public Health?

The rapid growth of artificial intelligence is reshaping how infectious diseases are monitored, predicted, diagnosed, and managed. As healthcare systems face increasingly complex challenges—including emerging pathogens, antimicrobial resistance, climate-sensitive diseases, and future pandemic threats—AI in Public Health is emerging as a powerful tool for supporting evidence-based decision-making across clinical practice, public health, and scientific research.

The Lancet framework developed by Odone et al. (2026) provides a comprehensive overview of how AI can contribute to infectious disease prevention and management. From disease surveillance and outbreak forecasting to pathogen characterization and drug discovery, AI is already influencing multiple aspects of modern public health systems.

However, the study also makes it clear that AI is not a standalone solution. Its success will depend on data quality, ethical governance, transparency, interdisciplinary collaboration, and rigorous real-world validation. The future of public health will likely involve close partnerships between human expertise and AI-powered technologies, combining the strengths of both to improve population health outcomes.

10.1 Key Findings from The Lancet Study

Several important themes emerge from the Lancet analysis of AI in Public Health.

First, AI has the potential to improve infectious disease surveillance by integrating diverse data sources and enabling real-time monitoring of disease activity. Advanced analytical systems can help public health agencies detect outbreaks earlier, identify emerging threats, and strengthen epidemic preparedness (Odone et al., 2026).

Second, AI-powered forecasting models can support disease prediction by combining epidemiological, environmental, climate, genomic, and mobility data. These capabilities can improve risk assessment and help health authorities implement preventive measures before outbreaks escalate.

Third, AI is increasingly contributing to clinical infectious disease management. Applications such as diagnostic decision support, medical imaging analysis, treatment optimization, and antimicrobial stewardship demonstrate how AI can assist healthcare professionals in delivering more effective care.

The study also highlights the growing importance of AI in pathogen characterization, vaccine development, and drug discovery. By accelerating data analysis and supporting scientific research, AI may help researchers respond more quickly to future infectious disease threats (Odone et al., 2026).

At the same time, the authors emphasize that challenges related to bias, privacy, transparency, regulation, and validation must be addressed to ensure responsible implementation.

10.2 Opportunities for Researchers and Policymakers

The findings presented by Odone et al. (2026) offer valuable insights for both researchers and policymakers.

For researchers, AI provides opportunities to analyze increasingly complex datasets, explore novel scientific questions, and develop innovative approaches to infectious disease prevention and management. The integration of genomic, environmental, epidemiological, and clinical data may open new pathways for understanding disease dynamics and improving public health interventions.

For policymakers, AI in Public Health offers tools that can strengthen surveillance systems, support preparedness planning, improve healthcare efficiency, and enhance decision-making during public health emergencies. Investments in digital infrastructure, data governance, workforce development, and interdisciplinary collaboration will be essential for maximizing these benefits.

The study also highlights the importance of establishing clear ethical and regulatory frameworks. Policymakers must ensure that AI systems are transparent, equitable, secure, and aligned with public health goals. Building public trust will be critical for the successful adoption of AI technologies in healthcare and public health settings.

By addressing these challenges proactively, governments and institutions can create environments where AI contributes positively to population health while minimizing potential risks.

10.3 The Road Ahead

Looking ahead, the future of AI in Public Health appears both promising and complex. Advances in machine learning, deep learning, large language models, and data integration technologies are expected to further expand the capabilities of AI-driven health systems.

Future public health strategies may increasingly rely on AI-powered surveillance networks, predictive analytics, environmental monitoring systems, and One Health frameworks that connect human, animal, and environmental health data. Such approaches could improve preparedness for infectious disease outbreaks and strengthen global health security (Odone et al., 2026).

Nevertheless, technological innovation alone will not guarantee success. Effective implementation requires high-quality data, robust governance structures, continuous evaluation, and meaningful collaboration among public health professionals, clinicians, researchers, policymakers, and technology developers.

Ultimately, the question is not whether AI will replace public health professionals—it will not. Rather, the future lies in how effectively artificial intelligence can augment human expertise and support better decision-making. The Lancet study suggests that when implemented responsibly, AI can become a valuable partner in disease prevention, public health preparedness, and scientific discovery.

As infectious disease threats continue to evolve, AI in Public Health may play a central role in helping societies build more resilient, responsive, and data-driven health systems for the future.

Reference

Odone, A., Barbati, C., Amadasi, S., Schultz, T., & Resnik, D. B. (2026). Artificial intelligence and infectious diseases: an evidence-driven conceptual framework for research, public health, and clinical practice. The Lancet Infectious Diseases, 26, e152–e167. https://doi.org/10.1016/S1473-3099(25)00412-8